Certara ... More than 2,400 companies and 23 global regulatory agencies have adopted Certara technology solutions ... More than 90% of all novel drugs approved by the US FDA since 2014 were supported by Certara services or technology ... Certara Inc.
RADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq. CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2025 ... .
) Certara Reports SecondQuarter 2025 Financial Results... RADNOR, PA- August 6, 2025-- Certara, Inc ... The increase in software bookings was primarily due to strength in Certara's core biosimulation software and contribution from Chemaxon ... About Certara.
) Management's Discussion and Analysis of Financial Condition and Results of Operations ...ExecutiveOverview ... On average, the pharmaceutical industry spends more than $270 billion annually on research and development ("R&D") ... Certara Inc.
Certara, Inc ...C/O CERTARA, INC., 4 RADNOR CORPORATE CENTER, SUITE 350 3 ... C/O CERTARA, INC ... (1) Each restricted stock unit ("RSU") was granted on June 1, 2024, under the Certara, Inc ... Certara Inc.
) Item 5.07 Submission of Matters to a Vote of Security Holders. On May 21, 2025, Certara, Inc. (the "Company") held its annual meeting of stockholders ... The final results of the votes regarding each proposal are set forth below. 1 ... Certara Inc.